Health Alert:

Joslin is following the events with regard to the Coronavirus (2019-nCoV). For the health and safety of our patients, visitors, and staff we are following recommendations of the Massachusetts Department of Public Health and the Centers for Disease Control. Those agencies are reporting a low risk for people in the United States to contract Coronavirus but encourage these prevention practices.

Alert Close

Dr. Kyoungmin Park focuses on investigating the molecular mechanisms underlying insulin’s action on the vascular wall and developing new therapeutic drugs for macrovascular complications, atherosclerosis in Type 2 diabetes. Additionally, working to determine the role of autoimmunity or autoimmune disease in the severity and development of atherosclerosis in Type 1 diabetes, diabetes-related disease, including cardiovascular disease.

University of Oklahoma Health Sciences Center

ADA Fellowship

Contact Information

Office Phone

(617) 309-2660

Kyoungmin.park [at] joslin.harvard.edu

News Related to Kyoungmin Park

Research may show way to minimize complications after heart treatment

BOSTON – (October 1, 2019) – People with diabetes are much more likely to develop heart disease than those without the condition. They also are several times more likely to develop complications after...
Read more on Research may show way to minimize complications after heart treatment

Research may show way to minimize complications after heart treatment

Insulin may drive the clogging of stents that often follows coronary angioplasties in people with diabetes. BOSTON – (October 1, 2019) – People with diabetes are much more likely to develop heart...
Read more on Research may show way to minimize complications after heart treatment

Joslin researchers uncover protective factor in diabetic eye disease

Increased levels of RBP3 both protect against and treats diabetic retinopathy BOSTON – (July 3, 2019) – Researchers at Joslin Diabetes Center have shown that a protein found in the eye can protect...
Read more on Joslin researchers uncover protective factor in diabetic eye disease